Technology News and Research

RSS

CQDM, OCE grant $1.5M to speed up drug discovery and development in Quebec-Ontario Life Sciences Corridor

CQDM and Ontario Centres of Excellence will fund five highly innovative and unconventional game-changing research and development projects to accelerate drug discovery in the Quebec-Ontario Life Sciences Corridor. Partners are granting $1.5M to Quebec-based and, for the first time, Ontario-based researchers thanks to the partnership with OCE through CQDM's 2014 Explore Program, one of CQDM's flagship programs focusing on early concept validation of cutting-edge technologies that address the most crucial needs in drug discovery and development.

17 Jun 2015

GOJO SMARTLINK OBV System launched for collecting hand hygiene and PPE compliance metrics

GOJO Industries, the inventors of PURELL Advanced Hand Sanitizer, announced today that it has launched its GOJO SMARTLINK Observation (OBV) System, a mobile application that connects to GOJO SMARTLINK web-based software and allows for the electronic collection and collation of hand hygiene and PPE compliance metrics.

16 Jun 2015

Kaiser Permanente wins 2015 CIO 100 Award for using health IT to improve quality and care delivery

Kaiser Permanente recently was honored by IDG's CIO magazine as one of the 2015 CIO 100 award winners for using technology to improve the health care experience for patients and their families.

16 Jun 2015

CyMedica Orthopedics closes $11.5 million Series A financing

CyMedica Orthopedics, Inc. announced today that it has closed an extension to its Series A financing. The Series A financing was led by investors Research Corporation Technologies, Inc., a Tucson-based venture capital firm, and California Technology Ventures, LLC, a Pasadena-based venture capital fund. The financing also included participation from existing investor Aphelion Capital (Mill Valley, CA) and the founding group of investors.

16 Jun 2015

Pulmatrix announces new inhaled anti-infective therapy to treat CF-associated fungal infections

Pulmatrix, Inc., a clinical stage biopharmaceutical company developing innovative inhaled therapies for serious pulmonary diseases, today announced a new drug candidate, PUR1900, an inhaled anti-infective to treat fungal infections associated with cystic fibrosis (CF).

16 Jun 2015

Pulmatrix completes previously announced merger and closes $10 million in private placement

Pulmatrix, Inc., previously known as Ruthigen, Inc., today announced the completion of its previously announced merger, effective June 15, 2015, and the closing of a private placement generating aggregate gross proceeds of $10.0 million. Participants in the private placement included pre-merger investors in Pulmatrix such as funds affiliated with 5AM Ventures, ARCH Venture Partners and Polaris Partners, as well as funds affiliated with Altitude Life Science Ventures.

16 Jun 2015

Pulmatrix signs ex-U.S. development agreement with Mylan for bronchodilator therapy

Pulmatrix, a clinical stage biopharmaceutical company developing innovative inhaled therapies for serious pulmonary diseases, today announced that it has entered into an ex-U.S. development agreement with Mylan N.V., one of the world's leading global pharmaceutical companies.

16 Jun 2015

Improving air quality could prevent pollution-related deaths worldwide

Improving air quality -- in clean and dirty places -- could reduce pollution-related deaths worldwide by millions of people each year. That finding comes from a team of environmental engineering and public health researchers who developed a global model of how changes in outdoor air pollution could lead to changes in the rates of health problems such as heart attack, stroke and lung cancer.

16 Jun 2015

Limeade announces acquisition of 9Slides

Limeade, an award-winning employee engagement company, today announced it acquired 9Slides, a leading mobile multimedia learning solution. The 9Slides acquisition demonstrates how Limeade stays ahead in the competitive corporate wellness market.

16 Jun 2015

Stony Brook University, CadheRx Therapeutics sign licensing agreement for anti-cancer technology

Stony Brook University has entered into a licensing agreement with a startup company, CadheRx Therapeutics, to develop and market an anti-cancer technology discovered by Sabine Brouxhon, MD, Clinical Associate Professor in the Department of Emergency Medicine at Stony Brook University School of Medicine.

16 Jun 2015

Discovery could help scientists reduce global vitamin A deficiency

A research team's discovery of new information about how plants synthesize carotenoids, precursors for vitamin A that are essential for plant development and survival, and human health, could help scientists increase the levels of provitamin A in food crops and reduce global vitamin A deficiency.

16 Jun 2015

Mayo Clinic, United Therapeutics partner to build and operate new lung restoration center on Mayo campus

Mayo Clinic in Jacksonville, Fla., and United Therapeutics Corporation today announced a collaboration to build and operate a lung restoration center on the Mayo campus. The goal is to significantly increase the volume of lungs for transplantation by preserving and restoring selected marginal donor lungs, making them viable for transplantation. The restored lungs will be made available to patients at Mayo Clinic and other transplant centers throughout the United States.

16 Jun 2015

DSM Sinochem Pharmaceuticals supports WHO’s ‘Call to Action’ on antimicrobial resistance

Following the Global Health Summit in Uppsala (Sweden) on 2-3 June, 2015, DSM Sinochem Pharmaceuticals pledged its commitment to the WHO’s ‘Call to Action’ on antimicrobial resistance issued at the Summit. One of the biggest opportunities to maintain the effectiveness and availability of antibiotics is responsible waste management, to date a highly undervalued dimension in the debate around resistance. DSP promised to use its expertise and influence in this area to help curb antimicrobial resistance.

16 Jun 2015

Supporting Innovation in Life Sciences

In this interview, News-Medical speaks to Ger Brophy about the importance of supporting technological innovation in the life sciences.

15 Jun 2015

Juniper announces enrollment of first patient in COL-1077 Phase II trial to reduce pain during endometrial biopsy

Juniper Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development of therapeutics for women's health, announced today the first patient has been enrolled in a Phase II clinical trial of COL-1077, a 10% lidocaine bioadhesive gel that is intended as an acute-use anesthetic during minimally invasive gynecologic procedures.

15 Jun 2015

Philips introduces new Anatomically Intelligent Ultrasound tool

Royal Philips today announced the introduction of HeartModelA.I., a new Anatomically Intelligent Ultrasound (AIUS) tool that brings advanced quantification, automated 3D views and robust reproducibility to cardiac ultrasound imaging.

13 Jun 2015

UCLA Medical Group earns five-star ranking from CAPG for patient care capabilities

The UCLA Medical Group has again earned the highest rating possible in an annual survey conducted by CAPG, an association representing physician organizations in 38 states, Washington, D.C., and Puerto Rico.

13 Jun 2015

Promising results for multi-source DBS in Parkinson’s disease

Deep-brain stimulation targeting the subthalamic nucleus with a multiple-source constant-current device effectively suppresses motor symptoms in patients with advanced Parkinson’s disease, report researchers.

12 Jun 2015

Ludwig Cancer Research announces opening of new branch in Lausanne, Switzerland

Ludwig Cancer Research announced today that it is opening a new Branch in Lausanne, Switzerland. The Branch will be focused primarily on applied cancer immunology and the design of novel molecular and cell-based immunotherapies. It will also develop technologies enabling the efficient, safe application of those therapies to as many patients as possible.

12 Jun 2015

Researchers working on new system that can detect patient's antibiotic resistance in 30 minutes

A new device being developed by medical experts will transform the time it takes to detect antibiotic resistance in patients from several days to just half an hour.

12 Jun 2015

Technology News and Research

CQDM, OCE grant $1.5M to speed up drug discovery and development in Quebec-Ontario Life Sciences Corridor

GOJO SMARTLINK OBV System launched for collecting hand hygiene and PPE compliance metrics

Kaiser Permanente wins 2015 CIO 100 Award for using health IT to improve quality and care delivery

CyMedica Orthopedics closes $11.5 million Series A financing

Pulmatrix announces new inhaled anti-infective therapy to treat CF-associated fungal infections

Pulmatrix completes previously announced merger and closes $10 million in private placement

Pulmatrix signs ex-U.S. development agreement with Mylan for bronchodilator therapy

Improving air quality could prevent pollution-related deaths worldwide

Limeade announces acquisition of 9Slides

Stony Brook University, CadheRx Therapeutics sign licensing agreement for anti-cancer technology

Discovery could help scientists reduce global vitamin A deficiency

Mayo Clinic, United Therapeutics partner to build and operate new lung restoration center on Mayo campus

DSM Sinochem Pharmaceuticals supports WHO’s ‘Call to Action’ on antimicrobial resistance

Supporting Innovation in Life Sciences

Juniper announces enrollment of first patient in COL-1077 Phase II trial to reduce pain during endometrial biopsy

Philips introduces new Anatomically Intelligent Ultrasound tool

UCLA Medical Group earns five-star ranking from CAPG for patient care capabilities

Promising results for multi-source DBS in Parkinson’s disease

Ludwig Cancer Research announces opening of new branch in Lausanne, Switzerland

Researchers working on new system that can detect patient's antibiotic resistance in 30 minutes

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News